Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $120.04 Analyst target: $130.62 Upside: 8.81%
Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware.
See the full interactive analysis & chart →Informational only — not investment advice.